These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 24218134)

  • 1. Hepcidin-25 concentrations are markedly increased in patients with chronic kidney disease and are inversely correlated with estimated glomerular filtration rates.
    Troutt JS; Butterfield AM; Konrad RJ
    J Clin Lab Anal; 2013 Nov; 27(6):504-10. PubMed ID: 24218134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepcidin and proinflammatory markers in children with chronic kidney disease: A case-control study
.
    Goyal KK; Saha A; Sahi PK; Kaur M; Dubey NK; Goyal P; Upadhayay AD
    Clin Nephrol; 2018 May; 89(5):363-370. PubMed ID: 29451472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum Hepcidin and Iron Indices Affect Anemia Status Differently According to the Kidney Function of Non-Dialysis Chronic Kidney Disease Patients: Korean Cohort Study For Outcome in Patients with Chronic Kidney Disease (KNOW-CKD).
    Lee SW; Kim YH; Chung W; Park SK; Chae DW; Ahn C; Kim YS; Sung SA
    Kidney Blood Press Res; 2017; 42(6):1183-1192. PubMed ID: 29227972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepcidin--a potential novel biomarker for iron status in chronic kidney disease.
    Zaritsky J; Young B; Wang HJ; Westerman M; Olbina G; Nemeth E; Ganz T; Rivera S; Nissenson AR; Salusky IB
    Clin J Am Soc Nephrol; 2009 Jun; 4(6):1051-6. PubMed ID: 19406957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting the hepcidin-ferroportin pathway in anaemia of chronic kidney disease.
    Sheetz M; Barrington P; Callies S; Berg PH; McColm J; Marbury T; Decker B; Dyas GL; Truhlar SME; Benschop R; Leung D; Berg J; Witcher DR
    Br J Clin Pharmacol; 2019 May; 85(5):935-948. PubMed ID: 30677788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of hepcidin and anemia in early chronic kidney disease.
    Sonkar SK; Singh NK; Sonkar GK; Pandey S; Bhosale V; Kumar A; Usman K
    Saudi J Kidney Dis Transpl; 2019; 30(2):315-324. PubMed ID: 31031367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepcidin and disordered mineral metabolism in chronic kidney disease.
    Carvalho C; Isakova T; Collerone G; Olbina G; Wolf M; Westerman M; Gutiérrez OM
    Clin Nephrol; 2011 Aug; 76(2):90-8. PubMed ID: 21762639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum hepcidin-25 and response to intravenous iron in patients with non-dialysis chronic kidney disease.
    Chand S; Ward DG; Ng ZY; Hodson J; Kirby H; Steele P; Rooplal I; Bantugon F; Iqbal T; Tselepis C; Drayson MT; Whitelegg A; Chowrimootoo M; Borrows R
    J Nephrol; 2015 Feb; 28(1):81-8. PubMed ID: 24687402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepcidin Response to Iron Therapy in Patients with Non-Dialysis Dependent CKD: An Analysis of the FIND-CKD Trial.
    Gaillard CA; Bock AH; Carrera F; Eckardt KU; Van Wyck DB; Bansal SS; Cronin M; Meier Y; Larroque S; Roger SD; Macdougall IC
    PLoS One; 2016; 11(6):e0157063. PubMed ID: 27276035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Inflammation on Ferritin, Hepcidin and the Management of Iron Deficiency Anemia in Chronic Kidney Disease.
    Ueda N; Takasawa K
    Nutrients; 2018 Aug; 10(9):. PubMed ID: 30150549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone marrow iron distribution, hepcidin, and ferroportin expression in renal anemia.
    Bârsan L; Stanciu A; Stancu S; Căpuşă C; Brătescu L; Mandache E; Radu E; Mircescu G
    Hematology; 2015 Oct; 20(9):543-52. PubMed ID: 25745821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepcidin and risk of anemia in CKD: a cross-sectional and longitudinal analysis in the CKiD cohort.
    Atkinson MA; Kim JY; Roy CN; Warady BA; White CT; Furth SL
    Pediatr Nephrol; 2015 Apr; 30(4):635-43. PubMed ID: 25380788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum hepcidin level correlates with hyperlipidemia status in patients following allograft renal transplantation.
    Xue D; He X; Zhou C
    Transplant Proc; 2014; 46(1):156-9. PubMed ID: 24507043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Anemia of chronic diseases in the early stages of chronic kidney disease as a risk factor for cardiovascular complications in patients with glomerulonephritis].
    Markina MV; Milovanova LY; Lysenko LV; Milovanova SY; Volkov AV; Beketov VD; Lebedeva MV; Nezhdanov KS; Moiseev SV
    Ter Arkh; 2024 Jul; 96(6):606-613. PubMed ID: 39106502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum hepcidin-25 levels in patients with chronic kidney disease are independent of glomerular filtration rate.
    Peters HP; Laarakkers CM; Swinkels DW; Wetzels JF
    Nephrol Dial Transplant; 2010 Mar; 25(3):848-53. PubMed ID: 19854845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute-Phase Proteins and Iron Status in Cats with Chronic Kidney Disease.
    Javard R; Grimes C; Bau-Gaudreault L; Dunn M
    J Vet Intern Med; 2017 Mar; 31(2):457-464. PubMed ID: 28140480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relation of hepcidin to iron disorders, inflammation and hemoglobin in chronic kidney disease.
    Mercadal L; Metzger M; Haymann JP; Thervet E; Boffa JJ; Flamant M; Vrtovsnik F; Houillier P; Froissart M; Stengel B;
    PLoS One; 2014; 9(6):e99781. PubMed ID: 24978810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepcidin/Ferritin Ratios Differ Among Non-Dialyzed Chronic Kidney Disease Patients, and Patients on Hemodialysis and Peritoneal Dialysis.
    Niikura T; Maruyama Y; Nakashima S; Matsuo N; Tanno Y; Ohkido I; Yokoyama K; Yamamoto H; Yokoo T
    Ther Apher Dial; 2019 Aug; 23(4):341-346. PubMed ID: 30411489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of serum NGAL and hepcidin levels in chronic kidney disease patients.
    Avci Çiçek E; Rota S; Dursun B; Kavalci E
    Ren Fail; 2016; 38(1):35-9. PubMed ID: 26627016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of different iron deficiency cutoffs with adverse outcomes in chronic kidney disease.
    Eisenga MF; Nolte IM; van der Meer P; Bakker SJL; Gaillard CAJM
    BMC Nephrol; 2018 Sep; 19(1):225. PubMed ID: 30208847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.